In conclusion, our study suggested that miR-596-3p/YAP1 pathway may provide a promising therapeutic strategy for brain metastasis of NSCLC, which may mitigate brain metastasis development and behavior, leading to an improvement of prognosis for patients with metastatic brain cancer. The gene discussed is YAP1; the disease is non-small cell lung carcinoma.